Clinical trial
Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and…
NCT00498433 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00498433 |
|---|---|
| Title | Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension |
| Official title | Part 1: An Open Label Pilot Study to Determine Interstitial and Tissue Concentrations of Aliskiren and Effects on the Renin- Angiotensin System (RAS) in Fat and Skeletal Muscle of Hypertensive Patients With Abdominal Obesity. Part 2: A Randomized, Double Blind, 12-weeks Parallel Group Study to… |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension, Abdominal Obesity |
| Intervention type | Drug |
| Interventions | Aliskiren, Amlodipine, Placebo of Aliskiren, Placebo of amlodipine |
| Enrollment | 46 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Jul 10, 2007 |
| Last update posted | Sep 10, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: